Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Vectura Group enters global development agreement with Dynavax for smart nebuliser technology

Aug. 17, 2017

Beijing Marino Biotechnology presents new CAR-T cells expressing non-functional EGFR

Aug. 17, 2017

Fate Therapeutics describes novel immune cell modulation compositions

Aug. 17, 2017

FDA removes clinical hold on phase III trial of Multikine in head and neck cancer

Aug. 16, 2017

Bristol-Myers Squibb announces topline data from CheckMate214 phase III study

Aug. 16, 2017

IND application accepted for glioblastoma multiforme immunotherapy VBI-1901

Aug. 16, 2017

First-in-human results for CART-EGFRvIII cell therapy in patients with recurrent glioblastoma

Aug. 14, 2017

Sutro and Celgene refocus their immune-oncology collaboration

Aug. 14, 2017

Starpharma and Monash awarded funding from SIEF STEM+ Business Fellowship Program

Aug. 11, 2017

Takeda forms immuno-oncology research collaboration with Shattuck

Aug. 11, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...